| __ |
Sufentanil Citrate |
Dzuveo® |
For the management of acute moderate to severe pain in adult patients |
Rapid Review Complete |
22nd December 2023 |
 |
| 25030 |
Sulthaime |
Ospolot® |
Sulthiame (Ospolot®) oral suspension is indicated for the treatment of Self-Limited Epilepsy with Centrotemporal Spikes (SeLECTS) (former Rolandic epilepsy) in children and adolescents aged three years and above who are non-respondent/intolerant to other treatments or without other therapeutic alternatives. |
Rapid Review Complete |
27th May 2025 |
|
| - |
Sunitinib |
Sutent® |
As second-line treatment of patients with gastro-intestinal stromal tumours (GIST); As second line treatment for patients with metastatic renal cell carcinoma (mRCC) |
Assessment process complete |
9th November 2006 |
|
